TNG Pharmaceuticals

Jenny Corbin

Louisville, KY USA

TNG Pharmaceuticals is furthering the development of a patented vaccine. FlyVax will systematically eradicate the horn flies which are plaguing cattle. The horn fly is a bloodsucking parasite that causes an average weight loss of 20 - 40 lbs per cow prior to slaughter, and a 50% reduction in milk yield per lifetime of a dairy cow. FlyVax alleviates customer pain by systemically decreasing horn fly populations by 50% each life cycle thus creating higher beef production and milk yield while lowering the amount of labor necessary for fly control. The thirty-six million cattle born each year represent a recurring revenue stream.